8 results
2021 ACR/VF Guidelines for Management of Polyarteritis Nodosa (PAN)

#PAN #Polyarteritis #Nodosa #ACR2021 #Management #rheumatology #algorithm #vasculitis
Guidelines for Management ... ) #PAN #Polyarteritis ... #Nodosa #ACR2021 ... #Management #rheumatology ... #algorithm #vasculitis
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
Polyarteritis Nodosa (PAN ... Algorithm - ACR ... high-dose oral or pulse ... #Treatment #ACR2021 ... #rheumatology
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Polyarteritis Nodosa (PAN ... pubmed.ncbi.nlm.nih.gov/34235884/ PAN ... #Treatment #ACR2021 ... #Guidelines #algorithm ... #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Algorithm - ACR ... Active Severe → Pulse ... of Preference (Can ... #Treatment #ACR2021 ... #rheumatology
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
) - Vasculitis Management ... Algorithm - ACR ... → High-dose IV pulse ... #Treatment #ACR2021 ... #rheumatology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... DVT = deep vein ... Malignancy #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... and incidental DVT ... without concomitant DVT ... Anticoagulation #Management ... #Hematology #Oncology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... • Treatment algorithms ... Thrombocythemia #ET #hematology ... #diagnosis #management ... #hematology